Agenus (AGEN) Earnings Date & Reports

Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

AGEN is expected to report earnings to rise 2,500.00% to -25 cents per share on November 10

Q3'26

Est.

$-0.26

Q2'26

Missed

by $0.07

Q1'26

Beat

by $1.67

Q4'25

Missed

by $0.04

Q3'25

Beat

by $2.22

The last earnings report on August 06 showed earnings per share of 0 cents, missing the estimate of 5 cents. With 85.42K shares outstanding, the current market capitalization sits at 425.88M.

View a ticker or compare two or three

AGEN

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for AGEN